🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesSURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input Page 6

SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input

Admin Wed, Apr 16, 2025 at 7:09 AM 40 replies 1,896 viewsPage 6 of 8
CryptoCarl
Member
789
3,456
May 2024
Arizona
Apr 16, 2025 at 3:39 PM#26

Congrats Admin!! Keep going — you're doing incredible. 🎉

Last edited: Apr 16, 2025 at 7:39 PM
8 19CryptoCarl, MariaRD, AussieAnna and 5 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Apr 16, 2025 at 3:56 PM#27

Slightly tangential to SURPASS-CVOT tirzepatide but mike_mod reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Apr 16, 2025 at 8:56 PM
20 3lisa_labSD, adam_van, Dr.SurgeonPGH and 17 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Apr 16, 2025 at 4:13 PM#28

100%. My provider said the same thing about SURPASS-CVOT.

1 22tampaLisa73
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Apr 16, 2025 at 4:30 PM#29

Reading this thread on SURPASS-CVOT tirzepatide hits close to home. Dad of 2 checking in — I started at 285 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 60 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about SURPASS-CVOT — take the leap. It was the best health decision I have ever made. ❤️

4 16Dr.PainCLE, mike_mealprep, NicoleRaleigh and 1 other
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Apr 16, 2025 at 4:47 PM#30

As a healthcare provider, I want to add some clinical context to this discussion on SURPASS-CVOT tirzepatide cardiovascular.

Building on what Dr.ObesityLA said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
46 23LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 43 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register